CSE1L, chromosome segregation 1 like, 1434

N. diseases: 163; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0242231
Disease: Coronary Stenosis
Coronary Stenosis
0.010 GeneticVariation disease BEFREE Coronary artery stenosis (CAS >50% narrowing of at least one coronary artery) was detected in 223 patients (40.5%). 28766048 2018
CUI: C0346429
Disease: Multiple malignancy
Multiple malignancy
0.010 Biomarker phenotype BEFREE CAS-viewer is a web-based application for transcript isoform-driven integration of multi-omics data in multiple cancer types and will aid in the visualization and possible discovery of biomarkers for cancer by integrating multi-omics data from TCGA. 29697367 2018
CUI: C0409959
Disease: Osteoarthritis, Knee
Osteoarthritis, Knee
0.010 Biomarker disease BEFREE This prospective cohort study aimed to evaluate the outcome and survivorship of the native patella in computer-assisted TKA (CAS TKA) implanted for primary knee osteoarthritis, and to determine the predictive factors of secondary patellar resurfacing (SPR). 28889222 2018
CUI: C0577631
Disease: Carotid Atherosclerosis
Carotid Atherosclerosis
0.010 GeneticVariation disease BEFREE All subjects were included either in the carotid atherosclerosis (AS) group or the control group according to the CAS diagnosis criteria. 30186852 2018
CUI: C0742468
Disease: Central nervous system lesion
Central nervous system lesion
0.010 Biomarker disease BEFREE Objective intracranial response was achieved in 20 (87·0%; 95% CI 66·4-97·2) of 23 patients with measurable baseline CNS lesions in EXP2-3A, five (55·6%; 21·2-86·3) of nine patients in EXP3B, and 26 (53·1%; 38·3-67·5) of 49 patients in EXP4-5. 30413378 2018
CUI: C0877008
Disease: Enzyme inhibition disorder
Enzyme inhibition disorder
0.010 Biomarker phenotype BEFREE Similarly docking studies predicted interaction of the most active compounds with both CAS and PAS of either AChE or BChE with mixed type of enzyme inhibition confirmed by kinetic studies. 30567381 2018
Attention deficit hyperactivity disorder
0.010 Biomarker disease BEFREE The planning and attention assessment of DN: CAS revealed high sensitivity and specificity in diagnosing ADHD, thus suggesting that DN: CAS might be an effective tool in diagnosing ADHD. 30541503 2018
CUI: C0002726
Disease: Amyloidosis
Amyloidosis
0.010 AlteredExpression disease BEFREE The structural arrangement of the enzyme, which features a narrow gorge that separates the catalytic and peripheral anionic subsites (CAS and PAS, respectively), inspired the development of bivalent ligands that are able to bind and block the catalytic activity of the CAS as well as the role of the PAS in beta amyloid () fibrillogenesis. 28570763 2017
CUI: C0007103
Disease: Malignant neoplasm of endometrium
Malignant neoplasm of endometrium
0.010 Biomarker disease BEFREE The combination of CTNB1, XPO2, and CAPG achieved 95% sensitivity and 96% specificity for the discrimination of these subtypes.<b>Conclusions:</b> We developed two uterine aspirate-based signatures to diagnose EC and classify tumors in the most prevalent histologic subtypes. 28790116 2017
CUI: C0011847
Disease: Diabetes
Diabetes
0.010 Biomarker disease BEFREE Findings were similar for CAS; compared with no diabetes or CHD, CAS odds increased for participants with diabetes alone (1.53, 95% CI 1.50-1.56), CHD alone (1.72, 95% CI 1.68-1.76), and both diabetes and CHD (2.57, 95% CI 2.49-2.66). 28224925 2017
CUI: C0019829
Disease: Hodgkin Disease
Hodgkin Disease
0.010 Biomarker disease BEFREE Main results were significant decreases of HD symptoms from before to after treatment on HD:CAS and HDSI scores and a decrease in the number of problematic sexual behaviors during the course of therapy. 28602666 2017
CUI: C0020179
Disease: Huntington Disease
Huntington Disease
0.010 Biomarker disease BEFREE Main results were significant decreases of HD symptoms from before to after treatment on HD:CAS and HDSI scores and a decrease in the number of problematic sexual behaviors during the course of therapy. 28602666 2017
CUI: C0029463
Disease: Osteosarcoma
Osteosarcoma
0.010 Biomarker disease BEFREE Taken together, our results demonstrate that the CSE1L-MSH6 axis has an important role in osteosarcoma progression. 28387323 2017
CUI: C0040021
Disease: Thromboangiitis Obliterans
Thromboangiitis Obliterans
0.010 Biomarker disease BEFREE <sup>99</sup>Tc<sup>m</sup>-octreotide scintigraphy and serum levels of calsequestrin, uveal auto-antigen with coiled-coil domains and ankyrin repeats (UACA) and G2s antibodies were detected before and after treatment.Results<sup>99</sup>Tc<sup>m</sup>-octreotide scintigraphy was positive in active TAO patients (97%) with elevated uptake ratio (UR) (P<0.05), and showed a significant correlation with CAS (r=0.816, P<0.01). 28387769 2017
CUI: C0042769
Disease: Virus Diseases
Virus Diseases
0.010 Biomarker group BEFREE Cas proteins utilize these crRNAs, which contain spacer sequences that can be derived from mobile genetic elements, to mediate immunity during a reoccurring virus infection. 28238733 2017
CUI: C0206526
Disease: Tuberculosis, Multidrug-Resistant
Tuberculosis, Multidrug-Resistant
0.010 Biomarker disease BEFREE Beijing strains were more significantly associated with MDR TB than CAS and EAI lineages. 28374900 2017
CUI: C0585442
Disease: Osteosarcoma of bone
Osteosarcoma of bone
0.010 Biomarker disease BEFREE Taken together, our results demonstrate that the CSE1L-MSH6 axis has an important role in osteosarcoma progression. 28387323 2017
CUI: C0860659
Disease: Aloof
Aloof
0.010 Biomarker disease BEFREE In order to evaluate whether brassinosteroids (BS) and green light regulate the transcription of plastid genes in a cross-talk with cytokinins (CKs), transcription rates of 12 plastid genes (ndhF, rrn23, rpoB, psaA, psaB, rrn16, psbA, psbD, psbK, rbcL, atpB, and trnE/trnY) as well as the accumulation of transcripts of some photoreceptors (PHYA, CRY2, CRY1A, and CRY1B) and signaling (SERK and CAS) genes were followed in detached etiolated barley leaves exposed to darkness, green or white light ±1μm 24-epibrassinolide (EBL). 27998756 2017
Squamous cell carcinoma of the head and neck
0.010 Biomarker disease BEFREE CRISPR/Cas gene editing is the newest technology with the ability to delete, mutate or replace genes of interest and has great potential for treating HNSCCs. 28438299 2017
CUI: C1332986
Disease: Childhood Osteosarcoma
Childhood Osteosarcoma
0.010 Biomarker disease BEFREE Taken together, our results demonstrate that the CSE1L-MSH6 axis has an important role in osteosarcoma progression. 28387323 2017
CUI: C0011334
Disease: Dental caries
Dental caries
0.010 Biomarker disease BEFREE Caries-associated bacteria showed the highest relative activity in caries lesions (e.g. lactobacilli CAC: 177.5 ± 46.0%) and lower activities on sound surfaces (e.g. lactobacilli CAS: 96.3 ± 31.5%), whereas asaccharolytic fusobacteria were most active on sound surfaces and less active in caries lesions (CFS: 275.7 ± 171.1%; CAS: 205.8 ± 114.3%; CAC: 51.1 ± 19.0%). 27595541 2016
CUI: C0333519
Disease: Caries (morphologic abnormality)
Caries (morphologic abnormality)
0.010 Biomarker disease BEFREE Caries-associated bacteria showed the highest relative activity in caries lesions (e.g. lactobacilli CAC: 177.5 ± 46.0%) and lower activities on sound surfaces (e.g. lactobacilli CAS: 96.3 ± 31.5%), whereas asaccharolytic fusobacteria were most active on sound surfaces and less active in caries lesions (CFS: 275.7 ± 171.1%; CAS: 205.8 ± 114.3%; CAC: 51.1 ± 19.0%). 27595541 2016
CUI: C0549473
Disease: Thyroid carcinoma
Thyroid carcinoma
0.010 Biomarker disease BEFREE By using immunohistochemistry (IHC) we found significantly increased IHC scores of CAS in primary papillary (PTC) and medullary (MTC), but not in follicular (FTC) thyroid carcinoma compared to non-tumorous (NT) thyroid tissue. 26892809 2016
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.010 Biomarker disease BEFREE Prosurvival function of the cellular apoptosis susceptibility/importin-α1 transport cycle is repressed by p53 in liver cancer. 24799195 2014
Liver and Intrahepatic Biliary Tract Carcinoma
0.010 Biomarker disease BEFREE Prosurvival function of the cellular apoptosis susceptibility/importin-α1 transport cycle is repressed by p53 in liver cancer. 24799195 2014